MarketFriction

Amerise Biosciences Ltd

BSE 531681 · Plastic Products - Industrial
₹0.78 -3.70%
BSE close2026-10-01
Market cap₹5.35 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.000.000.040.000.000.000.190.060.070.040.080.00
Expenses0.040.060.020.050.030.020.080.070.110.030.020.08
Operating Profit-0.04-0.060.02-0.05-0.03-0.020.11-0.01-0.040.010.06-0.08
OPM %50.00%57.89%-16.67%-57.14%25.00%75.00%
Other Income0.000.000.000.000.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax-0.04-0.060.02-0.05-0.03-0.020.11-0.01-0.040.010.06-0.08
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-0.04-0.060.02-0.05-0.03-0.020.11-0.01-0.040.010.06-0.08
EPS in Rs-0.01-0.010.00-0.01-0.00-0.000.02-0.00-0.010.000.01-0.01
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales0.000.000.001.180.000.009.580.010.040.000.000.19
Expenses0.030.940.021.180.150.179.030.130.190.180.240.24
Operating Profit-0.03-0.94-0.020.00-0.15-0.170.55-0.12-0.15-0.18-0.24-0.05
OPM %0.00%5.74%-1,200.00%-375.00%5.26%7.69%-26.32%
Other Income0.000.000.000.000.00-0.170.000.000.000.190.260.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax-0.03-0.94-0.020.00-0.15-0.340.55-0.12-0.150.010.02-0.05
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-0.03-0.94-0.020.00-0.15-0.340.55-0.12-0.150.010.02-0.05
EPS in Rs-0.00-0.14-0.000.00-0.02-0.050.08-0.02-0.020.000.00-0.01
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%%%-24%
Compounded Profit Growth10%16%29%-200%
Stock Price CAGR-6%-15%9%25%
Return on Equity-2%1%-1%0%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital6.616.616.616.616.616.616.616.616.616.616.616.61
Reserves-0.05-0.07-1.01-1.03-1.03-1.18-1.52-0.97-1.09-1.23-1.23-1.21
Borrowings0.000.000.000.000.000.000.000.080.090.000.000.00
Other Liabilities0.000.000.040.010.020.600.546.270.040.013.082.03
Total Liabilities6.566.545.645.595.606.035.6311.995.655.398.467.43
Fixed Assets0.000.000.000.000.000.000.000.000.000.000.000.00
CWIP0.000.000.000.000.000.000.000.000.000.000.000.00
Investments4.825.892.342.310.545.373.044.694.572.272.383.77
Other Assets1.740.653.303.285.060.662.597.301.083.126.083.66
Total Assets6.566.545.645.595.606.035.6311.995.655.398.467.43
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0.271.08-3.56-0.04-1.784.89-0.390.06-0.13-0.173.07-1.06
Cash from Investing Activity0.32-1.073.550.031.77-4.890.39-0.150.130.27-3.071.63
Cash from Financing Activity-0.590.000.000.000.000.000.000.080.01-0.090.000.00
Net Cash Flow0.000.00-0.01-0.01-0.010.01-0.01-0.010.000.010.000.57
Free Cash Flow0.271.08-3.56-0.04-1.784.89-0.390.06-0.13-0.173.07-1.06
CFO/OP-540%-3,600%379%200%-3,260%229%11%108%113%-1,706%442%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1,382.67236.980.000.00
Inventory Days0.000.00
Days Payable
Cash Conversion Cycle1,382.67236.980.000.00
Working Capital Days1,376.48-1.91-1,460.00-182.50
ROCE %-0.73%-0.46%-15.49%-0.36%0.00%-2.72%-6.46%10.18%-2.12%-2.73%0.19%0.37%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Public100.00%100.00%100.00%100.01%100.00%100.00%100.00%99.99%100.00%99.99%100.00%100.00%
No. of Shareholders20,43520,83123,48523,32327,07735,14236,59536,21735,67635,18034,51933,848

Fundamentals

Market Cap₹ 5.35 Cr.
Current Price₹ 0.81
Book Value₹ 0.82
ROCE0.37 %
ROE0.37 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)-24%
Compounded Profit Growth (TTM)-200%
Standalone figures.
Valuation
Market capRs 5 Cr
Enterprise valueRs 5 Cr
Price to book0.95x
Earnings yield-0.97%
P/E, 3-year average398.07x
P/B, 3-year average0.88x
P/E, 5-year average270.82x
P/B, 5-year average1.02x
Profitability
ROE0.37%
ROCE0.37%
ROA0.25%
ROE, 3-year average-0.73%
ROCE, 3-year average-0.72%
ROA, 3-year average-0.77%
ROE, 5-year average1.18%
ROCE, 5-year average1.18%
ROA, 5-year average0.51%
ROIC (approx.)-1.04%
Other income / net worth4.81%
Growth
Profit growth (latest year)100.00%
Profit growth QoQ-233.33%
Per share
EPS (TTM)Rs -0.01
EPS (latest year)Rs 0.00
EPS (latest quarter)Rs -0.01
EPS, 3-year averageRs -0.01
EPS, 5-year averageRs 0.01
Book value per shareRs 0.82
Cash flow per shareRs -0.16
Free cash flow per shareRs -0.16
Efficiency
Cash conversion cycle0 days
Working capital days-182 days
Leverage
Cash and bankRs 1 Cr
Net debtRs -1 Cr
Owners' fund to total sources72.68%
Cash flow
Cash from Operating Activity (latest year)Rs -1 Cr
Cash from Investing Activity (latest year)Rs 2 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -1 Cr
Cash from ops / profit, 5 years5.71x
Statement figures
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs -0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 7 Cr
ReservesRs -1 Cr
Shareholders' fundsRs 5 Cr
Total assetsRs 7 Cr
InvestmentsRs 4 Cr
Other liabilitiesRs 2 Cr
Shares outstanding (crore)6.61
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 0.95 is at the 33th percentile (median 1.02).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period531681Nifty 50Difference
1 week-1.3%-2.8% +1.5 pts
1 month-7.1%-6.8% -0.4 pts
3 months-4.9%-7.6% +2.7 pts
3 years+25.8%+14.2% +11.6 pts
5 years-56.7%+27.9% -84.6 pts

Red flags

F-score 4 of 6
explainHigh accruals Profit exceeded operating cash by 15% of total assets in 2026
lookProfit leans on other income Other income was 1300% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹0 Cr -100.0% vs Jun 2025. Net loss ₹0 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Supreme Industries Ltd43,77142.420.7 %
Astral Ltd36,93962.419.2 %
Garware Hi Tech Films Ltd16,30142.018.1 %
Finolex Industries Ltd9,37915.211.8 %
Time Technoplast Ltd9,07918.516.5 %
Kingfa Science & Technology (India) Ltd8,84239.223.2 %
Prince Pipes & Fittings Ltd2,83027.26.03 %
Apollo Pipes Ltd2,2581.23 %
Jain Irrigation Systems Ltd2,0655.30 %
Jai Corp Ltd1,61117.111.8 %
Premier Polyfilm Ltd1,00728.828.9 %
R M Drip & Sprinklers Systems Ltd1,00428.538.3 %
Prakash Pipes Ltd59112.012.4 %
Shish Industries Ltd5741686.80 %
Dhabriya Polywood Ltd50015.425.6 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Amerise Biosciences Ltd?

Amerise Biosciences Ltd (531681) has a market capitalisation of Rs 5.35 Cr. at the 2026-10-01 close.

What were Amerise Biosciences Ltd's latest quarterly results?

In the Jun 2026 quarter, Amerise Biosciences Ltd sales was Rs 0 Cr (-100.0% vs Jun 2025) with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03